Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract B032: Tumor PD-L1 suppresses NK cell function through crosstalk with dendritic cells and IL-12 release

Jiuling Yang, Deniz Goekbuget, Li Wang, Hannah Driks, Lawrence Fong, Robert Blelloch

Cancer Immunol Res (2025) 13 (2_Supplement): B032.

https://doi.org/10.1158/2326-6074.IO2025-B032

Published: 23 February 2025

View articletitled, Abstract B032: Tumor PD-L1 suppresses NK cell function through crosstalk with dendritic cells and IL-12 release

Journal Articles

Abstract A020: Induction of non-canonical CAR T cell states in multiple myeloma patients with durable responses

Kai Wu, Karen Law, Guy Ledergor, Chang Liu, Serena Kwek, Marcel Arias Badia, Zenghua Fan, Vibha Gurunathan, Rachel Wolters, Averey Lea, Matthew Clark, Alexander Cheung, Jeffrey Wolf, Thomas Martin, Justin Eyquem, Lawrence Fong

Cancer Immunol Res (2025) 13 (2_Supplement): A020.

https://doi.org/10.1158/2326-6074.IO2025-A020

Published: 23 February 2025

View articletitled, Abstract A020: Induction of non-canonical CAR T cell states in multiple myeloma patients with durable responses

Journal Articles

Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancer

Aram Lyu, Zenghua Fan, Matthew Clark, Averey Lea, Diamond Luong, Ali Setayesh, Alec Starzinski, Rachel Wolters, Marcel Arias-Badia, Kate Allaire, Kai Wu, Vibha Gurunathan, Laura Valderrábano, Xiao Wei, Richard Miller, Eliezer Van Allen, Lawrence Fong

Cancer Immunol Res (2025) 13 (2_Supplement): PR003.

https://doi.org/10.1158/2326-6074.IO2025-PR003

Published: 23 February 2025

View articletitled, Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancer

Journal Articles

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Cancer Immunol Res (2024) 12 (6): 704–718.

https://doi.org/10.1158/2326-6066.CIR-22-0306

Published: 04 June 2024

View articletitled, Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Includes: Supplementary data

Journal Articles

PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

Jiuling Yang, Li Wang, James R. Byrnes, Lisa L. Kirkemo, Hannah Driks, Cassandra D. Belair, Oscar A. Aguilar, Lewis L. Lanier, James A. Wells, Lawrence Fong, Robert Blelloch

Cancer Immunol Res (2024) 12 (5): 575–591.

https://doi.org/10.1158/2326-6066.CIR-23-0722

Published: 02 May 2024

View articletitled, PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

Includes: Supplementary data

Journal Articles

Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer

Hewitt Chang, Jaqueline Marquez, Brandon K. Chen, Daniel M. Kim, Michael L. Cheng, Eric V. Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S. Kwek, Eric D. Chow, Mark Bridge, Rahul R. Aggarwal, Terence W. Friedlander, Eric J. Small, Mark Anderson, Lawrence Fong

Cancer Immunol Res (2024) 12 (4): 453–461.

https://doi.org/10.1158/2326-6066.CIR-23-0184

Published: 02 April 2024

View articletitled, Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer

Includes: Supplementary data

Journal Articles

Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T

Li Zhang, Harini Kandadi, Hai Yang, Jason Cham, Tao He, David Y. Oh, Nadeem A. Sheikh, Lawrence Fong

Cancer Immunol Res (2020) 8 (12): 1496–1507.

https://doi.org/10.1158/2326-6066.CIR-20-0252

Published: 01 December 2020

View articletitled, Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T

Includes: Supplementary data

Journal Articles

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

Samantha K. Greaney, Alain P. Algazi, Katy K. Tsai, Kathryn T. Takamura, Lawrence Chen, Christopher G. Twitty, Li Zhang, Alan Paciorek, Robert H. Pierce, Mai H. Le, Adil I. Daud, Lawrence Fong

Cancer Immunol Res (2020) 8 (2): 246–254.

https://doi.org/10.1158/2326-6066.CIR-19-0359

Published: 03 February 2020

View articletitled, Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

Includes: Supplementary data

Journal Articles

Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer

Xiao X. Wei, Stephen Chan, Serena Kwek, Jera Lewis, Vinh Dao, Li Zhang, Matthew R. Cooperberg, Charles J. Ryan, Amy M. Lin, Terence W. Friedlander, Brian Rini, Christopher Kane, Jeffry P. Simko, Peter R. Carroll, Eric J. Small, Lawrence Fong

Cancer Immunol Res (2016) 4 (11): 948–958.

https://doi.org/10.1158/2326-6066.CIR-16-0042

Published: 31 October 2016

View articletitled, Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract B147: Randomized phase II trial of a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with recurrent prostate cancer (NCT01341652)

Douglas G. McNeel, Lawrence Fong, Emmanuel S. Antonarakis, Glenn Liu

Cancer Immunol Res (2016) 4 (1_Supplement): B147.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B147

Published: 03 January 2016

View articletitled, Abstract B147: Randomized phase II trial of a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with recurrent prostate cancer (NCT01341652)

Journal Articles

Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab

Serena S. Kwek, Jera Lewis, Li Zhang, Vivian Weinberg, Samantha K. Greaney, Andrea L. Harzstark, Amy M. Lin, Charles J. Ryan, Eric J. Small, Lawrence Fong

Cancer Immunol Res (2015) 3 (9): 1008–1016.

https://doi.org/10.1158/2326-6066.CIR-14-0227

Published: 03 September 2015

View articletitled, Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract B032: Tumor PD-L1 suppresses NK cell function through crosstalk with dendritic cells and IL-12 release

Abstract A020: Induction of non-canonical CAR T cell states in multiple myeloma patients with durable responses

Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancer

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer

Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T

Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses

Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer

Abstract B147: Randomized phase II trial of a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with recurrent prostate cancer (NCT01341652)

Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only